News & Publications

June 5, 2025 - Engineered heart muscle allografts for heart repair in primates and humans

June 5, 2025 - ADMET-AI Enables Interpretable Predictions of Drug-Induced Cardiotoxicity

June 5, 2025 - CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity

June 5, 2025 - Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target

January 9, 2024 - Tachycardia-induced metabolic rewiring as a driver of contractile dysfunction

January 9, 2024 - Studying Long QT Syndrome Caused by NAA10 Genetic Variants Using Patient-Derived Induced Pluripotent Stem Cells.

January 9, 2024 - Statins improve endothelial function via suppression of epigenetic-driven EndMT.

January 9, 2024 - Greenstone Biosciences is proud to be a sponsor of the 2023 Stanford Drug Discovery Symposium

September 27, 2023 - Greenstone Biosciences Secures $2.75M to Advance Revolutionary Cardiotoxicity Detection Technology

September 27, 2023 - Greenstone Biobank Poster

August 11, 2023 - Financial Conflict of Interest (FCOI) Policy for NIH-Funded Research

July 24, 2023 - FDA Modernization Act 2.0 Paves the Way to Computational Biology and Clinical Trials in a Dish

July 13, 2023 - Congratulation to Greenstone Biosciences co-founder for becoming the President of American Heart Association

May 8, 2023 - Leveraging Physiology and Artificial Intelligence to Deliver Advancements in Healthcare

Greenstone Biosciences co-founded Joseph C. Wu, and SAB James Zou writes on the relevant AI models in healthcare and how physiological data has been harnessed by AI to advance healthcare.

May 8, 2023 - Researchers solve mystery of how statins improve blood vessel health

Statins designed to lower cholesterol have long been noted to work in mysterious ways to improve other aspects of cardiovascular health. A Stanford Medicine and Greenstone Biosciences-led study by Prof Joseph Wu and colleagues uncover how they do it.

February 1, 2023 - Greenstone Biosciences on a Quest for Duchenne Muscular Dystrophy Therapeutics with New Funding from CIRM

January 18, 2023 - Current and future perspectives of single-cell multi-omics technologies in cardiovascular research

December 12, 2022 - Greenstone co-founder Joseph Wu inducted into NAI Class of 2022

December 7, 2022 - CIRM funds Greenstone Biosciences with $1.35M to accelerate drug discovery using patient - derived induced pluripotent stem cells

December 1, 2022 - Greenstone Bio adds Axel Brunger to the Scientific Advisory Board

October 13, 2022 - CIRM Awards $1.3 million to Greenstone Bio for Innovative Cardiovascular Stem Cell Research

August 23, 2022 - Greenstone Biosciences, Inc. Announces Collaboration with the Maryland Stem Cell Research Fund to Provide Curated Induced Pluripotent Stem Cell Lines to Stem Cell Investigators Across the State of Maryland

August 19, 2022 - Greenstone Biosciences makes human induced pluripotent stem cell lines available to academic institutions for free

July 18, 2022 - Greenstone Bio welcomes Nobel Laureate Brian Kobilka to their Scientific Advisory Board

July 4, 2022 - Greenstone Bio welcomes James Zou to our Scientific Advisory Board

July 4, 2022 - Shifting machine learning for healthcare from development to deployment and from models to data

July 1, 2022 - Stanford’s Joseph Wu to be president of the American Heart Association

June 27, 2022 - The Many Uses of CRISPR: Scientists Tell All

June 15, 2022 - Creative Medical Technology Holdings Announces Agreement with Greenstone Biosciences, Inc. for Development of a Next Generation iPSC Pipeline for its ImmCelz® Immunotherapy Platform

April 29, 2022 - Marijuana linked to heart disease; supplement may mitigate risk, study reports

Marijuana use and heart-attack risk were correlated in a large human study, Stanford scientists and their collaborators found. A molecule in soybeans may counteract these effects.

April 29, 2022 - Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation

October 21, 2019 - Joseph Wu, MD, PhD, elected to the National Academy of Medicine

December 16, 2016 - Induced pluripotent stem cell technology: a decade of progress.